Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin - Sato, Ken; Naganuma, Atsushi; Nagashima, Tamon; Hoshino, Takashi; Uehara, Daisuke; Arai, Yousuke; Horiuchi, Katsuhiko; Yuasa, Kazuhisa; Takayama, Hisashi; Arai, Hirotaka; Hatanaka, Takeshi; Ohyama, Tatsuya; et al. (Hepatology research, 2018)
Keywords: Body mass index; chronic hepatitis C; Creatinine; genotype 2; Genotypes; Hepatitis C; Hyperuricemia; Interferon; Ribavirin; sofosbuvir; Uric acid; sofosbuvir; ribavirin; genotype 2; uric acid; chronic hepatitis C